Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:00:33 UTC
Update Date2021-09-14 14:58:52 UTC
HMDB IDHMDB0013946
Secondary Accession Numbers
  • HMDB13946
Metabolite Identification
Common Name8-Hydroxycarvedilol
Description8-Hydroxycarvedilol belongs to the class of organic compounds known as carbazoles. Carbazoles are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. 8-Hydroxycarvedilol is a very strong basic compound (based on its pKa). 8-Hydroxycarvedilol is only found in individuals that have used or taken Carvedilol.
Structure
Data?1582753156
SynonymsNot Available
Chemical FormulaC24H26N2O5
Average Molecular Weight422.4736
Monoisotopic Molecular Weight422.184171952
IUPAC Name5-(2-hydroxy-3-{[2-(2-methoxyphenoxy)ethyl]amino}propoxy)-9H-carbazol-1-ol
Traditional Name5-(2-hydroxy-3-{[2-(2-methoxyphenoxy)ethyl]amino}propoxy)-9H-carbazol-1-ol
CAS Registry NumberNot Available
SMILES
COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N2
InChI Identifier
InChI=1S/C24H26N2O5/c1-29-20-9-2-3-10-21(20)30-13-12-25-14-16(27)15-31-22-11-5-7-18-23(22)17-6-4-8-19(28)24(17)26-18/h2-11,16,25-28H,12-15H2,1H3
InChI KeyGPPVNZVFGNMPNR-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as carbazoles. Carbazoles are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIndoles and derivatives
Sub ClassCarbazoles
Direct ParentCarbazoles
Alternative Parents
Substituents
  • Carbazole
  • Hydroxyindole
  • Indole
  • Phenoxy compound
  • Anisole
  • Phenol ether
  • Methoxybenzene
  • Alkyl aryl ether
  • 1-hydroxy-4-unsubstituted benzenoid
  • 1-hydroxy-2-unsubstituted benzenoid
  • Monocyclic benzene moiety
  • Benzenoid
  • Heteroaromatic compound
  • Pyrrole
  • 1,2-aminoalcohol
  • Secondary alcohol
  • Azacycle
  • Ether
  • Secondary aliphatic amine
  • Secondary amine
  • Alcohol
  • Organooxygen compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Organic oxygen compound
  • Amine
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.014 g/LALOGPS
logP3.03ALOGPS
logP2.85ChemAxon
logS-4.5ALOGPS
pKa (Strongest Acidic)9.69ChemAxon
pKa (Strongest Basic)8.69ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area95.97 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity117.62 m³·mol⁻¹ChemAxon
Polarizability46.01 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+197.93531661259
DarkChem[M-H]-196.24731661259
DeepCCS[M+H]+188.55430932474
DeepCCS[M-H]-186.19630932474
DeepCCS[M-2H]-220.2830932474
DeepCCS[M+Na]+196.03830932474
AllCCS[M+H]+204.232859911
AllCCS[M+H-H2O]+201.732859911
AllCCS[M+NH4]+206.532859911
AllCCS[M+Na]+207.132859911
AllCCS[M-H]-201.232859911
AllCCS[M+Na-2H]-201.432859911
AllCCS[M+HCOO]-201.732859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
8-HydroxycarvedilolCOC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N24796.0Standard polar33892256
8-HydroxycarvedilolCOC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N23771.0Standard non polar33892256
8-HydroxycarvedilolCOC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N24034.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
8-Hydroxycarvedilol,1TMS,isomer #1COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O)=C1[NH]2)O[Si](C)(C)C3949.3Semi standard non polar33892256
8-Hydroxycarvedilol,1TMS,isomer #2COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1[NH]23921.7Semi standard non polar33892256
8-Hydroxycarvedilol,1TMS,isomer #3COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1[NH]2)[Si](C)(C)C3973.8Semi standard non polar33892256
8-Hydroxycarvedilol,1TMS,isomer #4COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C3960.1Semi standard non polar33892256
8-Hydroxycarvedilol,2TMS,isomer #1COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1[NH]2)O[Si](C)(C)C3817.3Semi standard non polar33892256
8-Hydroxycarvedilol,2TMS,isomer #2COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O)=C1[NH]2)O[Si](C)(C)C)[Si](C)(C)C3939.7Semi standard non polar33892256
8-Hydroxycarvedilol,2TMS,isomer #3COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C)O[Si](C)(C)C3839.9Semi standard non polar33892256
8-Hydroxycarvedilol,2TMS,isomer #4COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1[NH]2)[Si](C)(C)C3852.8Semi standard non polar33892256
8-Hydroxycarvedilol,2TMS,isomer #5COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C3852.4Semi standard non polar33892256
8-Hydroxycarvedilol,2TMS,isomer #6COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C)[Si](C)(C)C3868.0Semi standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1[NH]2)O[Si](C)(C)C)[Si](C)(C)C3853.5Semi standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1[NH]2)O[Si](C)(C)C)[Si](C)(C)C3669.7Standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1[NH]2)O[Si](C)(C)C)[Si](C)(C)C4468.2Standard polar33892256
8-Hydroxycarvedilol,3TMS,isomer #2COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)O[Si](C)(C)C3779.8Semi standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #2COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)O[Si](C)(C)C3509.5Standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #2COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)O[Si](C)(C)C4258.1Standard polar33892256
8-Hydroxycarvedilol,3TMS,isomer #3COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C3874.6Semi standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #3COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C3628.5Standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #3COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C4462.3Standard polar33892256
8-Hydroxycarvedilol,3TMS,isomer #4COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C3817.6Semi standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #4COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C3569.1Standard non polar33892256
8-Hydroxycarvedilol,3TMS,isomer #4COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)[Si](C)(C)C4437.1Standard polar33892256
8-Hydroxycarvedilol,4TMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C3838.9Semi standard non polar33892256
8-Hydroxycarvedilol,4TMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C3534.4Standard non polar33892256
8-Hydroxycarvedilol,4TMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C)=C1N2[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C4162.1Standard polar33892256
8-Hydroxycarvedilol,1TBDMS,isomer #1COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O)=C1[NH]2)O[Si](C)(C)C(C)(C)C4202.1Semi standard non polar33892256
8-Hydroxycarvedilol,1TBDMS,isomer #2COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1[NH]24142.5Semi standard non polar33892256
8-Hydroxycarvedilol,1TBDMS,isomer #3COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1[NH]2)[Si](C)(C)C(C)(C)C4219.7Semi standard non polar33892256
8-Hydroxycarvedilol,1TBDMS,isomer #4COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C(C)(C)C4110.0Semi standard non polar33892256
8-Hydroxycarvedilol,2TBDMS,isomer #1COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1[NH]2)O[Si](C)(C)C(C)(C)C4236.2Semi standard non polar33892256
8-Hydroxycarvedilol,2TBDMS,isomer #2COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O)=C1[NH]2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4418.9Semi standard non polar33892256
8-Hydroxycarvedilol,2TBDMS,isomer #3COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C4223.1Semi standard non polar33892256
8-Hydroxycarvedilol,2TBDMS,isomer #4COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1[NH]2)[Si](C)(C)C(C)(C)C4323.2Semi standard non polar33892256
8-Hydroxycarvedilol,2TBDMS,isomer #5COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C4219.0Semi standard non polar33892256
8-Hydroxycarvedilol,2TBDMS,isomer #6COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4274.5Semi standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1[NH]2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4500.2Semi standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1[NH]2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4172.9Standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1[NH]2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4563.2Standard polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #2COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C4316.9Semi standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #2COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C4020.1Standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #2COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C4366.1Standard polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #3COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4442.1Semi standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #3COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4132.7Standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #3COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4522.3Standard polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #4COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4416.2Semi standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #4COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4043.9Standard non polar33892256
8-Hydroxycarvedilol,3TBDMS,isomer #4COC1=CC=CC=C1OCCN(CC(O)COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4520.0Standard polar33892256
8-Hydroxycarvedilol,4TBDMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4561.4Semi standard non polar33892256
8-Hydroxycarvedilol,4TBDMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4162.8Standard non polar33892256
8-Hydroxycarvedilol,4TBDMS,isomer #1COC1=CC=CC=C1OCCN(CC(COC1=CC=CC2=C1C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1N2[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4317.5Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 8-Hydroxycarvedilol GC-MS (Non-derivatized) - 70eV, Positivesplash10-03dm-3980000000-db38aab7af71901400192017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 8-Hydroxycarvedilol GC-MS (2 TMS) - 70eV, Positivesplash10-0kmi-2390120000-8fb846aa983d2692cd612017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 8-Hydroxycarvedilol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 10V, Positive-QTOFsplash10-00di-0450900000-bdef8f67caca741536c72016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 20V, Positive-QTOFsplash10-0kh9-2790200000-e072284bed0b3d3c4fde2016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 40V, Positive-QTOFsplash10-0pc0-6910000000-a977de859887adb889dc2016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 10V, Negative-QTOFsplash10-00di-0920700000-cfd2b483fbb0630d89cd2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 20V, Negative-QTOFsplash10-0002-0900000000-1cee942232f4a994849a2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 40V, Negative-QTOFsplash10-0002-1900000000-3db4678cdc558a9a931e2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 10V, Negative-QTOFsplash10-00di-0400900000-1f2ccfeeb5dd1ff7c0fb2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 20V, Negative-QTOFsplash10-00r2-2940400000-6113e741b77e77e7200c2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 40V, Negative-QTOFsplash10-0002-0900000000-c4be53c61d8b7d170ad92021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 10V, Positive-QTOFsplash10-00di-0270900000-95e8d02d6ac06b2851882021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 20V, Positive-QTOFsplash10-0uk9-0590300000-2f7c87c4625f1ecc691b2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 8-Hydroxycarvedilol 40V, Positive-QTOFsplash10-0udi-2930000000-b9e31650dfeac34c4acb2021-09-22Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8155231
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound9979639
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Only showing the first 10 proteins. There are 18 proteins in total.

Enzymes

General function:
Involved in NADH dehydrogenase (ubiquinone) activity
Specific function:
Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone
Gene Name:
NDUFC2
Uniprot ID:
O95298
Molecular weight:
14187.3
References
  1. Oliveira PJ, Santos DJ, Moreno AJ: Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondria. Arch Biochem Biophys. 2000 Feb 15;374(2):279-85. [PubMed:10666308 ]
General function:
Involved in oxidoreductase activity
Specific function:
Key enzyme in purine degradation. Catalyzes the oxidation of hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric acid. Contributes to the generation of reactive oxygen species. Has also low oxidase activity towards aldehydes (in vitro).
Gene Name:
XDH
Uniprot ID:
P47989
Molecular weight:
146422.99
References
  1. Yue TL, McKenna PJ, Gu JL, Cheng HY, Ruffolo RE Jr, Feuerstein GZ: Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils. Cardiovasc Res. 1994 Mar;28(3):400-6. [PubMed:7909721 ]
General function:
Involved in peroxidase activity
Specific function:
May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells.
Gene Name:
PTGS1
Uniprot ID:
P23219
Molecular weight:
68685.82
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide.
Gene Name:
CYP3A4
Uniprot ID:
P08684
Molecular weight:
57255.585
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.
Gene Name:
CYP2C9
Uniprot ID:
P11712
Molecular weight:
55627.365
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.
Gene Name:
CYP2E1
Uniprot ID:
P05181
Molecular weight:
56848.42
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.
Gene Name:
CYP2D6
Uniprot ID:
P10635
Molecular weight:
55768.94
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
Gene Name:
CYP1A1
Uniprot ID:
P04798
Molecular weight:
58164.815
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin.
Gene Name:
CYP1A2
Uniprot ID:
P05177
Molecular weight:
58406.915
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Beta-adrenergic receptors mediate the catecholamine- induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity
Gene Name:
ADRB1
Uniprot ID:
P08588
Molecular weight:
51322.1
References
  1. Nichols AJ, Gellai M, Ruffolo RR Jr: Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fundam Clin Pharmacol. 1991;5(1):25-38. [PubMed:1712335 ]
  2. Nichols AJ, Sulpizio AC, Ashton DJ, Hieble JP, Ruffolo RR Jr: In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol. Pharmacology. 1989;39(5):327-36. [PubMed:2575762 ]
  3. Nichols AJ, Sulpizio AC, Ashton DJ, Hieble JP, Ruffolo RR Jr: The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors. Chirality. 1989;1(4):265-70. [PubMed:2577144 ]
  4. de Mey C, Breithaupt K, Schloos J, Neugebauer G, Palm D, Belz GG: Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans. Clin Pharmacol Ther. 1994 Mar;55(3):329-37. [PubMed:7908256 ]

Transporters

General function:
Involved in ATP binding
Specific function:
Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells
Gene Name:
ABCB1
Uniprot ID:
P08183
Molecular weight:
141477.3
References
  1. Wang EJ, Casciano CN, Clement RP, Johnson WW: Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors. Biochem Biophys Res Commun. 2001 Nov 30;289(2):580-5. [PubMed:11716514 ]
  2. Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K: Interaction of digoxin with antihypertensive drugs via MDR1. Life Sci. 2002 Feb 15;70(13):1491-500. [PubMed:11895100 ]
  3. Jonsson O, Behnam-Motlagh P, Persson M, Henriksson R, Grankvist K: Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity. Biochem Pharmacol. 1999 Dec 1;58(11):1801-6. [PubMed:10571255 ]
  4. Neuhoff S, Langguth P, Dressler C, Andersson TB, Regardh CG, Spahn-Langguth H: Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites. Int J Clin Pharmacol Ther. 2000 Apr;38(4):168-79. [PubMed:10783826 ]
  5. Hokama N, Hobara N, Sakai M, Kameya H, Ohshiro S, Sakanashi M: Influence of nicardipine and nifedipine on plasma carvedilol disposition after oral administration in rats. J Pharm Pharmacol. 2002 Jun;54(6):821-5. [PubMed:12078998 ]
  6. Kakumoto M, Sakaeda T, Takara K, Nakamura T, Kita T, Yagami T, Kobayashi H, Okamura N, Okumura K: Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Cancer Sci. 2003 Jan;94(1):81-6. [PubMed:12708479 ]
  7. Brodde OE, Kroemer HK: Drug-drug interactions of beta-adrenoceptor blockers. Arzneimittelforschung. 2003;53(12):814-22. [PubMed:14732961 ]

Only showing the first 10 proteins. There are 18 proteins in total.